These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
67 related items for PubMed ID: 6927483
21. [Calcium antagonists: an echocardiographic evaluation of the morphofunctional changes in the left ventricle]. Di Renzi L, Arata L, Pastore LR, Agati L, Penco M, Fedele F, Gargari T. Boll Soc Ital Cardiol; 1979; 24(9):963-76. PubMed ID: 553651 [No Abstract] [Full Text] [Related]
22. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo]. Cherchi A, Sau F, Mercuro G, Seguro C, Lai O. Clin Ter; 1985 May 31; 113(4):301-6. PubMed ID: 3893868 [No Abstract] [Full Text] [Related]
23. [Our experience on the clinical use of nadolol]. Trinchero R, Moratti M, Ghisio A, Pomari F, Artesani S, Barbano G. Minerva Cardioangiol; 1985 Oct 31; 33(10):629-34. PubMed ID: 2867492 [No Abstract] [Full Text] [Related]
24. [Effect of nifedipine on left ventricular function in arterial hypertension studied by Doppler echocardiography]. Walrabe D, Pál L, Homut V, Heinemann G. Kardiologiia; 1988 Jan 31; 28(1):78-9. PubMed ID: 3357301 [No Abstract] [Full Text] [Related]
25. [Relation of ECG and left ventricular parameters in hypertensive patients]. Cao ZM. Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Jun 31; 17(3):162-4. PubMed ID: 2598785 [No Abstract] [Full Text] [Related]
26. Assessment of left ventricular changes in systemic hypertension--before and after therapy. Arora R, Nair M, Gupta GD, Gupta MP. Indian Heart J; 1984 Jun 31; 36(3):155-60. PubMed ID: 6490046 [No Abstract] [Full Text] [Related]
29. [Evaluation of the phase-volume parameters of the left heart ventricle in patients with hypertension and nephrogenic arterial hypertension]. Nazar PS, Galitskiĭ IaD, Martyniuk ES. Vrach Delo; 1989 Jul 31; (7):75-7. PubMed ID: 2800510 [Abstract] [Full Text] [Related]
30. [Treatment of postoperative hypertensive crisis with labetalol: effects on left ventricular function]. Le Bret F, Turki S, Coriat P, Mouren S, Arthaud M, Viars P. Ann Fr Anesth Reanim; 1989 Jul 31; 8 Suppl():R93. PubMed ID: 2604278 [No Abstract] [Full Text] [Related]
31. [Myocardial hypertrophy and left ventricular function in hypertensive patients: Doppler echocardiographic evaluation]. Conforti G, Breglio R, Morgano G, Montemurro MV, Arrichiello P, Tesorio M, Petretta M, Bonaduce D. Cardiologia; 1988 Sep 31; 33(9):853-62. PubMed ID: 2976303 [No Abstract] [Full Text] [Related]
32. Treatment of essential hypertension. A comparison between nadolol, once daily, and propranolol, four times daily. Frithz G. Practitioner; 1982 Mar 31; 226(1365):562-4. PubMed ID: 7045847 [No Abstract] [Full Text] [Related]
33. Minoxidil, nadolol, and a diuretic. Once-a-day therapy for resistant hypertension. Spitalewitz S, Porush JG, Reiser IW. Arch Intern Med; 1986 May 31; 146(5):882-6. PubMed ID: 3963979 [Abstract] [Full Text] [Related]
34. A report on the clinical efficacy of nadolol--a new long acting beta-blocker. Hill LS, Fand RS. Ir Med J; 1979 Dec 31; 72(12):522-9. PubMed ID: 44273 [No Abstract] [Full Text] [Related]
35. [Field trial with a new betablocker (Solgol)]. Piergies A, Schimert G. MMW Munch Med Wochenschr; 1980 Oct 17; 122(42):1473-6. PubMed ID: 6110182 [Abstract] [Full Text] [Related]
36. [Mono- and bi-dimensional echocardiographic parameters in the assessment of left ventricular structure and function: normal values and evaluation of hypertensive heart disease]. Huml D, Numić N, Buksa M. Acta Med Iugosl; 1987 Oct 17; 41(1):3-21. PubMed ID: 2955670 [No Abstract] [Full Text] [Related]
37. [Effects of antihypertensive therapy with selective and non-selective beta blocking agents on dimensions and function of the left ventricle]. Seguro C, Sau F, Cherchi A. Cardiologia; 1991 Jan 17; 36(1):39-45. PubMed ID: 1678985 [Abstract] [Full Text] [Related]
38. Left ventricular structural and functional changes in young men at increased risk of developing essential hypertension. Assessment by echocardiography. Nielsen JR, Oxhøj H, Fabricius J. Ann Clin Res; 1988 Jan 17; 20 Suppl 48():16-8. PubMed ID: 2977934 [Abstract] [Full Text] [Related]
39. Isometric exercise before and after nadolol treatment in uncomplicated essential hypertension. Corea L, Bentivoglio M, Provvidenza M. Int J Clin Pharmacol Res; 1984 Jan 17; 4(1):35-40. PubMed ID: 6469432 [Abstract] [Full Text] [Related]
40. [Clinical evaluation of the hypotensive effects of nadolol]. Hanzlik J, Sodolski W, Stelmasiak T, Wolański I. Kardiol Pol; 1982 Jan 17; 25(2):101-6. PubMed ID: 6125620 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]